Lateef Investment Management Lp decreased its stake in Ims Health Holdings Inc (IMS) by 21.2% based on its latest 2016Q3 regulatory filing with the SEC. Lateef Investment Management Lp sold 1.25 million shares as the company’s stock rose 20.12% with the market. The institutional investor held 4.64M shares of the technology company at the end of 2016Q3, valued at $145.50 million, down from 5.89M at the end of the previous reported quarter. Lateef Investment Management Lp who had been investing in Ims Health Holdings Inc for a number of months, seems to be less bullish one the $10.33 billion market cap company. The stock last traded at $0 per share. It is down 19.76% since June 6, 2016 and is uptrending. It has outperformed by 12.33% the S&P500.
Lateef Investment Management Lp is a California-based institutional investor with more than $5.98 billion AUM in March, 2014. Taken from Lateef Investment Management latest Adv, the fund reported to have 28 full and part-time employees. Among which 5 performing investment advisory and research functions. The institutional investor had more than 2200 clients.
Insitutional Activity: The institutional sentiment decreased to 0.73 in Q3 2016. Its down 0.49, from 1.22 in 2016Q2. The ratio is negative, as 32 funds sold all IMS shares owned while 76 reduced positions. 23 funds bought stakes while 56 increased positions. They now own 300.69 million shares or 2.13% more from 294.44 million shares in 2016Q2. The New Jersey-based Prudential Inc has invested 0% in IMS Health Holdings Inc (NYSE:IMS). State Of Wisconsin Inv Board, a Wisconsin-based fund reported 96,260 shares. Moreover, Royal Bancorporation Of Canada has 0% invested in IMS Health Holdings Inc (NYSE:IMS) for 49,205 shares. Nicholas Wi has invested 0.29% of its portfolio in IMS Health Holdings Inc (NYSE:IMS). Cibc Asset Mgmt Inc, a Ontario – Canada-based fund reported 13,182 shares. Aviva Public Limited Liability Com, a United Kingdom-based fund reported 96,620 shares. Moreover, Delta Lloyd Nv has 0.01% invested in IMS Health Holdings Inc (NYSE:IMS) for 9,947 shares. Principal Fincl Group holds 17,699 shares or 0% of its portfolio. Gotham Asset Mngmt Ltd Liability Co holds 0.17% or 415,479 shares in its portfolio. Panagora Asset Management reported 361,959 shares or 0.05% of all its holdings. Calvert Inv Mgmt has 0.01% invested in the company for 9,330 shares. Daiwa Secs Grp Inc holds 0% of its portfolio in IMS Health Holdings Inc (NYSE:IMS) for 3,900 shares. The Maryland-based Brown Advisory Securities Limited Liability Corp has invested 0.1% in IMS Health Holdings Inc (NYSE:IMS). Lateef Investment Mgmt Ltd Partnership has 4.64 million shares for 5.95% of their US portfolio. Mizuho Trust And Bk Company accumulated 0.03% or 280,198 shares.
More notable recent IMS Health Holdings Inc (NYSE:IMS) news were published by: Wsj.com which released: “IMS Health, Quintiles to Merge in $8.75 Billion Deal” on May 03, 2016, also Bloomberg.com with their article: “IMS Health Pays Its CEO More Than IBM’s to Keep Him From Leaving” published on February 25, 2016, Law360.com published: “IMS Health Investor Seeks To Halt $9B Quintiles Merger” on May 17, 2016. More interesting news about IMS Health Holdings Inc (NYSE:IMS) were released by: Bloomberg.com and their article: “IMS Health CEO Awarded $23.5 Million in Shares, Topping Peers” published on January 06, 2016 as well as Streetinsider.com‘s news article titled: “Quintiles IMS Holdings (Q) Completes Merger of Equals Transaction Between IMS …” with publication date: October 03, 2016.
IMS Health Holdings Inc (NYSE:IMS) Ratings Coverage
Out of 7 analysts covering IMS Health Holdings Inc (NYSE:IMS), 5 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 71% are positive. IMS Health Holdings Inc has been the topic of 12 analyst reports since August 4, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Topeka Capital Markets on Friday, October 30. On Wednesday, February 24 the stock rating was initiated by Leerink Swann with “Outperform”. Mizuho maintained the shares of IMS in a report on Friday, October 30 with “Buy” rating. The stock has “Buy” rating given by Topeka Capital Markets on Thursday, February 4. The company was maintained on Monday, August 3 by Topeka Capital Markets. The stock has “Market Perform” rating given by Wells Fargo on Thursday, May 12. The firm earned “Overweight” rating on Wednesday, September 9 by Barclays Capital.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.